| ²é¿´: 369 | »Ø¸´: 0 | |||
| ¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßliuhaoyang½«ÔùËÍÄú 20 ¸ö½ð±Ò | |||
liuhaoyangÌú³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
USP-NF<1530>
|
||
| Quality attributes of synthetic peptide drug substances USP-NF<1530> |
» ²ÂÄãϲ»¶
»¯¹¤284Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
085701»·¾³¹¤³Ì317·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085701»·¾³¹¤³Ìרҵ£¬³õÊÔ305£¬¾ù¹ý¹ú¼ÒAÇøÏß
ÒѾÓÐ5È˻ظ´
Õе÷¼Á
ÒѾÓÐ16È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
³ÏÇóµ÷¼Á£¬323·Ö ÓÐרÀû/¿ÆÑÐ/ʵϰ¾Àú
ÒѾÓÐ7È˻ظ´
²ÄÁÏ325Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Öпƴó²ÄÁÏ299Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼Êõ312·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
081700ѧ˶һ־Ը±±¾©»¯¹¤´óѧÊý¶þÓ¢Ò»¹ýÁù¼¶ÓоºÈüÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´













»Ø¸´´ËÂ¥
6